Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学DLBCL CAR-T and Bispecific Research

Grzegorz Nowakowski

MD

🏢Mayo Clinic🌐USA

Professor of Medicine and Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Grzegorz Nowakowski is a DLBCL expert whose research has advanced molecular classification and novel combination therapies. His work on polatuzumab vedotin and bispecific antibodies has expanded treatment options for relapsed DLBCL. He has contributed to understanding double-hit lymphoma biology and developing risk-adapted treatment approaches.

Share:

🧪Research Fields 研究领域

DLBCL molecular classification
Polatuzumab vedotin
Novel DLBCL combinations
Double-hit lymphoma
Lymphoma prognostic models

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Grzegorz Nowakowski 的研究动态

Follow Grzegorz Nowakowski's research updates

留下邮箱,当我们发布与 Grzegorz Nowakowski(Mayo Clinic)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment